Supplementary Figures 1-2, Tables 1-4, Methods from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients

Authors:
  • RTRalph Tiedt
    Ralph Tiedt
  • EDElisa Degenkolbe
    Elisa Degenkolbe
  • PFPascal Furet
    Pascal Furet
  • BABrent A. Appleton
    Brent A. Appleton
  • SWSabrina Wagner
    Sabrina Wagner
  • JSJoseph Schoepfer
    Joseph Schoepfer
  • EBEmily Buck
    Emily Buck
  • DRDavid A. Ruddy
    David A. Ruddy
  • JMJohn E. Monahan
    John E. Monahan
  • MJMichael D. Jones
    Michael D. Jones
  • JBJutta Blank
    Jutta Blank
  • DHDorothea Haasen
    Dorothea Haasen
Open Access
Publisher website
Google Scholar
Abstract
Supplementary Figures 1-2, Tables 1-4, Methods from A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients